Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Wednesday preview: Fed minutes, Jet2 in the spotlight

(Sharecast News) - Investors' focus in the middle of the week will be on the minutes of the US central bank's most recent policy meeting.

They will be looking for insights into whether the Federal Reserve will start cutting interest rates again in September or October.

Against that backdrop, they will also be keeping a close eye on the latest trade headlines as the initial deadline for reaching deals with the US lapses today Wednesday.

In its place, President Donald Trump may issue new tariff announcement against more countries.

Also of considerable importance, overnight China's National Bureau of Statistics will release consumer price data for June.

Across the Channel, ECB vice-president Luis de Guindos will deliver a speech at 1100 BST.

On home shores, the Treasury will conduct an auction of 10-year Gilts at 0930 BST.

At 2301 BST, the Royal Institute of Chartered Surveyors will publish its UK House Price Balance for June.

On the corporate side of things, budget airline Jet2 is due to release its full fiscal year results.

In April, the carrier guided towards full-year group profits of between £565-570m - which was in line with expectations - and said that it would repurchase £250m-worth of its own shares.

However, it did not share any guidance regarding 2026, something that City analyst Michael Hewson hopes will change this time around.

"Interestingly there was little market reaction to the reluctance to provide any sort of guidance for 2026. Hopefully we'll get more detail on that as well as further updates when it comes to its summer and winter bookings."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.